Bringing Hope for
Better Health through
the Infinite Power of Science
Who We Are
Our Business
Member
Recruitment
What’s New
-
Orizuru Therapeutics, Inc. provided OZTx-410 for the first implantation case in a type 1 diabetes patient in the investigator-initiated clinical trial
-
Successful Development of Alternative Peptides to Growth Factors for Regenerative Medicine in Collaboration with PeptiGrowth Inc.
-
Announcement on the Start of Investigator-Initiated Clinical Trial of iPS cell-Derived Islet Cell Sheet Transplantation